Juan Carlos Quer - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Gastroenterologia Y Hepatologia|April 25, 2015

[Chronic hepatitis C: patients with mild disease]Juan Carlos Quer, Moisés Diago, Javier Crespo, et al.

Medicina Clinica|May 25, 2002

[Induction therapy with interferon alfa-2a in compensated hepatitis C virus-related cirrhosis. Randomized, multicenter study]Ramon Planas, Juan Carlos Quer, Jaime Enríquez, et al.

BMJ Open|November 24, 2024

OPTI-HEP-D: a protocol for an intervention study comprising screening and linkage to care of people living with hepatitis D in CataloniaAdriana Palom, Ariadna Rando-Segura, Gema Fernandez, et al.

Metabolism: Clinical and Experimental|June 14, 2023

Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLDAnna Marsal-Beltran, Adrià Rodríguez-Castellano, Brenno Astiarraga, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Gastroenterologia Y Hepatologia|April 25, 2015

[Chronic hepatitis C: patients with mild disease]Juan Carlos Quer, Moisés Diago, Javier Crespo, et al.

Medicina Clinica|May 25, 2002

[Induction therapy with interferon alfa-2a in compensated hepatitis C virus-related cirrhosis. Randomized, multicenter study]Ramon Planas, Juan Carlos Quer, Jaime Enríquez, et al.

BMJ Open|November 24, 2024

OPTI-HEP-D: a protocol for an intervention study comprising screening and linkage to care of people living with hepatitis D in CataloniaAdriana Palom, Ariadna Rando-Segura, Gema Fernandez, et al.

Metabolism: Clinical and Experimental|June 14, 2023

Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLDAnna Marsal-Beltran, Adrià Rodríguez-Castellano, Brenno Astiarraga, et al.

Pageof 1